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OBJECTIVE: This study provides the clinical pathological characteristics of 1301 cases of pediatric/adolescent
lymphomas in patients from different geographic regions of Brazil.
METHODS: A retrospective analyses of diagnosed pediatric lymphoma cases in a 10-year period was performed. We
believe that it represents the largest series of pediatric lymphomas presented from Brazil.
RESULTS: Non-Hodgkin lymphomas represented 68% of the cases, including those of precursor (36%) and mature
(64%) cell origin. Mature cell lymphomas comprised 81% of the B-cell phenotype and 19% of the T-cell phenotype.
Hodgkin lymphomas represented 32% of all cases, including 87% of the classical type and 13% of nodular
lymphocyte predominant type. The geographic distribution showed 38.4% of the cases in the Southeast region,
28.7% in the Northeast, 16.1% in the South, 8.8% in the North, and 8% in the Central-west region. The distribution
by age groups was 15–18 years old, 33%; 11–14 years old, 26%; 6–10 years old, 24%; and 6 years old or younger,
17%. Among mature B-cell lymphomas, most of the cases were Burkitt lymphomas (65%), followed by diffuse large
B-cell lymphomas (24%). In the mature T-cell group, anaplastic large cell lymphoma, ALK-positive was the most
prevalent (57%), followed by peripheral T-cell lymphoma, then not otherwise specified (25%). In the group of
classic Hodgkin lymphomas, the main histological subtype was nodular sclerosis (76%). Nodular lymphocyte
predominance occurred more frequently than in other series.
CONCLUSION: Some of the results found in this study may reflect the heterogeneous socioeconomical status and
environmental factors of the Brazilian population in different regions.
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INTRODUCTION
Lymphomas constitute about 10–12% of all malignancies
in pediatric patients.
1–3 About 7–10% are non-Hodgkin
lymphomas (NHLs), and 4–7% are Hodgkin lymphomas
(HLs).
2,4,5 There has been an overall increase in the
incidence of NHLs in the Western population over the last
two decades,
5,6 primarily in adult patients. The incidence of
NHLs among children younger than 15 years of age has
remained fairly constant, with a slight increase in incidence
for the 15- to 18-year-old population.
7
Childhood NHL differs from adult NHL with respect to
disease types, biological behavior, staging system, treat-
ment, and outcome. Whereas NHL in adults is more often
low to intermediate grade, the vast majority of NHLs in
children are high-grade lymphomas.
8 There is considerable
geographic variation in the incidence and distribution of
subtypes of lymphomas. In Equatorial Africa, almost 50% of
childhood cancers are lymphomas with a preponderance of
Burkitt lymphoma (BL). In Western countries, approxi-
mately one-third of childhood NHLs are lymphoblastic
lymphomas/leukemia (LL), 40% BL, 10–20% diffuse large B-
cell lymphoma (DLBCL), and 10–20% anaplastic large cell
lymphoma (ALCL); other types of NHLs are very rare.
9,10–14
HL represents approximately one-third of lymphomas in
children.
11,15,16 CHL is more prevalent, with few studies
reporting findings on nodular lymphocyte predominance
during childhood.
17–21
Brazil is the fifth largest country in the world. It has a
population of approximately 190 million people,
22 and it is
divided into five main large geographic regions (macro-
regions) with marked heterogeneity in socioeconomic
development, population density, and climatic character-
istics (http://countrystudies.us/brazil/).
The first report on cancer incidence among children and
adolescents in Brazil, performed by the population-based
cancer registry (PBCR), was recently published and showed
that the main groups of all cancers were leukemia (18–41%),
lymphoma (13–24%), and central nervous system tumors (7–
17%), considering different cancer based-region registers.
23,24
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1267In Brazil there is a complete lack of comprehensive
clinicopathological and epidemiological studies on pediatric
lymphomas, especially regarding the relationship between
geographic region and type of lymphoma. There are
isolated regional data referring to the association with
immunosuppression or socioeconomic status, viral infec-
tions, and different therapeutic protocols.
24–34
Herein, we present the clinicopathological evaluation of
what we believe to be the largest series (1301 cases) of
lymphomas in the Brazilian pediatric population, with
special consideration to histological subtype distribution in
all geographic regions, which may reflect the heterogeneous
socioeconomic and environmental status of the Brazilian
population in the various regions.
MATERIAL AND METHODS
Description of characteristics of geographic regions
A general description of all five geographic regions in
Brazil, including climate, population, and economic status,
is given below.
North Region. The equatorial North, also known as the
Amazon, is the country’s largest region, covering 45.3% of
the national territory. The climate is mainly humid tropical
forest. The North region has the lowest population density.
The per capita income is low.
Northeast Region. The Northeast region covers 18.3% of
the national territory. Its principal biome is the semi-arid
region, which is subject to prolonged periodic droughts. The
region has the country’s largest concentration of rural
population, and its living standards are the lowest in
Brazil. The per capita income is very low.
Southeast Region. The Southeast region corresponds to
10.9% of the national territory. The region has the densest
population in the country. It contains the mega-cities of Sa ˜o
Paulo and Rio de Janeiro. The region combines the highest
living standards in Brazil with pockets of urban poverty.
Originally, the principle biome in the Southeast was the
Atlantic Forest, but less than 10% of the original forest
remains.
South Region. The South region covers 6.8% of the
national territory. In addition to the Atlantic Forest and
pinewoods, the South contains Pampas grasslands. The per
capita income is above average.
The Center-West Region. The Center-West region covers
18.9% of the national territory. Its main biome is the cerrado,
the tropical savanna. It also includes the Pantanal wetlands
in the West. The per capita income varies from area to area:
it is low in most of the region, with the highest found in the
area where the Federal District is located.
Case selection
All cases of lymphomas diagnosed in children and
adolescents with available slides for review were retrieved
retrospectively from the files of Consultoria em Patologia
during the period of January 1999 and December 2009.
Consultoria em Patologia is the largest reference consulta-
tion service in anatomic pathology in Brazil and is located in
Botucatu, Sao Paulo State.
Hematoxylin and eosin and immunohistochemistry slides
of each case were reviewed. Additional immunohistochem-
istry studies were performed as needed, in addition to the
initial panel, to further classify lymphoma subtypes. Anti-
bodies used are shown in Table 1. Epstein-Barr virus status
was evaluated by immunohistochemistry for LMP-1 in BLs
and HLs. In special cases, EBER in situ hybridization was
also performed, mainly to confirm specific diagnosis.
Human T-cell leukemia virus-1 was not evaluated in the
study. Diagnosis criteria and lymphoma classification
applied to this review were those established by the 2008
World Health Organization (WHO) classification.
35 For
practical purposes, the final diagnosis of each case was
based on the specimens available for review from the files
only. Information on blood cell count, flow cytometry, and
bone marrow aspirate cytology were not usually available.
Consequently, in cases of lymphoblastic malignant neopla-
sias, for instance, leukemia versus lymphoma, we were
unable to discriminate between lymphoma and leukemia.
Clinical data
The clinical information included gender and age at
diagnosis (#18 years old). The cases were categorized further
into four groups according to age: 0–5, 6–10, 11–14, and 15–
18 years of age. The anatomic location, stage, laboratory tests,
treatment, and follow-up, when available, were obtained
from the referring hematologists/oncologists. All cases re-
trieved from the files were identified according to the five
geographic regions of Brazil mentioned above.
Subtypes of lymphomas
The lymphomas’ subtypes were defined according to the
WHO 2008 Classification of Tumors of Hematopoietic and
Lymphoid Tissues.
35 For global analyses, the cases were
divided into two main groups: NHL and HL. NHL was
divided further according to the immunophenotype in B-
cell and T-cell lineages, including the precursor and mature
Table 1 - Primary antibodies used for




CD20 L26 11200 MW; CB Dako
CD3 SP7 1200 S; CB Neomarkers
CD30 BerH2 1100 S; CB Dako
Granzime Gran-B 140 MW; CB Novocastra
TIA-1 2G9 1200 MW, CB Immunotech
Ki-67 MIB-1 14800 PC; CB Dako
LMP-1 CS1-4 12000 S; CB Dako
CD45RB PD7 1500 MW;CB Dako
CD15 Leu-M1 150 MW; CB Becton-Dickinson
CD10 56C6 1100 S; CB Novocastra
BCL-2 124 1400 MW; CB Dako
BCL-6 PG-B6P 1100 T+ S; TRIS Dako
IRF4/MUM-1 MUM1P 11200 S; CB Dako
ALK ALK-1 1200 S; TRIS Dako
EMA E29 1800 PC; CB Dako
PAX-5 24 1100 S; CB Becton-Dickinson
CD25 4C9 1200 S; EDTA Novocastra
CD23 SP23 1400 MW; CB Neomarkers
CD5 4C7 11600 S; CB Novocastra
TDT Polyclonal 1600 S; CB Dako
Cyclin D1 SP4 1100 S; CB Neomarkers
Ki-67 MIB-1 14800 PC; CB Dako
DAKO, Carpinteria, CA, USA; Neomarkers, Fremont, CA, USA, Novocastra,
United Kingdom; Abcam, San Francisco, CA, USA; RD, Minneapolis, MN,
USA: Immunotech, Marseille, France; Becton-Dickinson Biosciences,
Mountain View, CA, USA. Heat-induced epitope retrieval was employed.
MW: microwave oven, PC: pressure cooker, S: steamer, T: trypsin, CB:
citrate buffer.
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1268cell subtypes. HLs were subclassified into classical Hodgkin
lymphoma (CHL) and nodular lymphocyte predominant
(NLP) category. CHL was further subdivided into four
subtypes: nodular sclerosis (NS), mixed cellularity (MC),
lymphocyte rich, and lymphocyte depleted. All lymphoma
types were correlated with age group, gender, and geogra-
phic regions.
RESULTS
A total of 1301 cases of lymphoma involving pediatric/
adolescent patients (#18 years old) over an 11-year period
(1999–2009) were retrieved from the files of Consultoria em
Patologia. All cases were seen in consultation, in general, for
a second pathology diagnostic opinion. All geographic
regions of Brazil were represented in this series. All the
cases were divided into two major groups: NHL and HL.
NHL included 755 cases (58%), whereas HL accounted for
546 cases (42%), being 476 cases of CHL and 70 cases of
NLP. In the NHL group, 459 cases (60.8%) were B-cell lym-
phomas, and 296 cases (39.2%) were T-cell lymphomas,
including precursor and mature-cell origin in both lineages
(Fig. 1A). The age distribution in the four groups is shown
in Fig. 1B. Most of the cases belonged to the 15- to 18-year-
old age group (445 cases, 33%), followed by the 6- to 10-
year-old age group (333 cases, 25.6%) and the 11- to 14-year-
olds (304 cases, 23.4%) with the 0 to 5-year-old age group
having the lowest number of cases (219 cases, 17). Sixty-six
percent of all cases corresponded to patients 14 years old or
younger. The male gender was predominant in all groups
(Fig. 1C). The geographic distribution of all cases is
described in Table 2. Thirty-eight percent of the cases were
from the Southeast region followed by 29% from the
Northeast, 16% from the South, 8.8% in the North region,
Figure 1 – A, Global distribution of non-Hodgkin and Hodgkin pediatric lymphoma cases in Brazil. B, Distribution of all cases of
pediatric lymphoma by age groups. C, Distribution of all cases of pediatric lymphoma by gender.
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1269and 8% in the Central-West region. The mean age varied
from 9.7 years old in the North to 12.4 years old in the
South. The male–female ratio varied from 2.25 in the North
to 1.4 in the South.
The histological distribution of the lymphomas sub-
types according to the various regions showed that NHL
accounted for 50% in the North and 66% in the South with
about 58% in the other regions. HL varied from 50% in the
North and 34% in the South compared with NHL. When the
geographic distribution is evaluated in each group sepa-
rately (NHL and HL) the highest frequency corresponded to
the Southeast region (38%) and the lowest in the Central-
West region (8%), for both groups.
Non-Hodgkin lymphomas
Based on the WHO’s 2008 classification for hematolym-
phoid neoplasm,
35 NHL was separated into two main
groups: precursor and mature B-cell and T-cell hematolym-
phoid neoplasms.
Precursor lymphoid neoplasms
LLs accounted 272 (36%) of all NHL cases, with a male
predominance (178M/94F, ratio 1.9/1). The distribution
according to lineage revealed B-cells in 69 cases (25.3%), T-
cell in 161 cases (59.2%), and unclassified in 42 cases (15.5%).
Unclassified cases were defined by the absence of expres-
sion of lineage-specific markers using immunohistochem-
istry methodology. The geographical distribution is shown
in Table 3. Most of the cases were from the Southeastern
region, followed by the Northeastern and the South regions
(39%, 23.5%, and 23.2%, respectively). In almost all regions,
the predominant gender was male, except for B-cell LL in
the South, where females were twice as frequent as males.
Mature cell non-Hodgkin lymphomas
Mature cell NHLs corresponded to 483 (64%) of all NHL
cases, including 390 (81%) of B-cell and 93 (19%) cases of T-
cell. The distribution of mature NHL is shown in Fig. 2.
BL included 281 cases (58.2% of all mature lymphomas
and 65% of all mature B-cell lymphomas). It was by far the
most common B-cell lymphoma subtype, followed by
DLBCL with 92 cases (19% of all mature, 23.6% of mature
B). Seventy-two cases were DLBCL, not otherwise specified
(NOS), nine cases were T-cell-rich B-cell lymphoma, and 11
cases were mediastinal B-cell lymphoma variants. Twelve
cases were considered intermediate between DLBCL and
BL (2.5% of all mature cell lymphomas, 6.4% of B-cell
lymphomas). Only five cases were low-grade B-cell lym-
phomas (1.03%, 1.3%). In this low-grade group, one case
was follicular lymphoma, and four were extranodal
marginal zone lymphoma (MALT type).
The geographical distribution of NHL revealed that 39%
of the cases were from the Southeast followed by the
Northeast with 29% of the patients, Central-West with 15%
and a similar frequency in the North and the South at 8%
and 9%, respectively. The male–female ratio was 2.4/1
(278M/112F), (Table 4).
Mature T and T/NK-cell lymphoma
ALCL was the most common subtype in this group: 53
cases of ALCL ALK positive (11% of all mature NHL and
57% of all T-cell ones) cases and nine cases of ALCL ALK
negative. Males were predominant. The mean age was
11.8 years old for ALCL-ALK-positive and 16.3 years old for
ALCL-ALK-negative cases.
The other subtypes of mature T/NK cell lymphomas
included 23 cases of T-cell NOS (4% of all mature NHL and
25% of all T-cell lineage), five cases of T/NK lymphoma,
nasal type, one subcutaneous panniculitis-like T-cell lym-
phoma, and two cases of T-cell lymphoma associated with
HTLV-1 virus.
Table 5 shows the gender and geographic distribution for
the different T-cell NHL subtypes. T-cell lymphomas
presented with a more similar gender distribution than
the mature B-cell lymphomas. The geographic distribution
of the T-cells seemed to be more homogeneous than B-cell
lymphomas with no predominance of a specific geographic
region. A global overview of the distribution of all NHL, for
both precursor cells and mature cells derived by age group,
is shown in Fig. 3, and the frequency of age groups affected
in each geographic region is shown in Fig. 4.
Hodgkin lymphoma
HLs corresponded to 546 cases with 476 CHL (87%) and
70 (13%) NLP. The comparative frequency of CHL and NLP
is shown in Fig. 5. The geographic distribution for all cases
is shown in Table 6: the frequency of CHL increased from
North to South and the frequency of NLP was the reverse.
The Southeast was the most prevalent region with 194 cases,
followed by the Northeast with 136 cases, the South with 63
cases, 45 cases in the North, and 38 cases in the Central-West
region, as shown in Table 5.
In the group of CHL, most of the cases were of the NS
subtype (361 cases, 75.8%) with the remaining as follows:
Table 2 - Overview of all cases of pediatric lymphomas
distributed by geographic region according to mean age,












Mean (y) 9.7 10.9 11.2 12.4 10.9
Range (y) 1–18 1–18 3–18 1–18 1–18
Gender
Male 79 255 61 123 328
Female 35 118 44 86 172
Lymphoma type
NHL 57 (50%) 212 (57%) 62 (59%) 138 (66%) 286 (57%)
HL 57 (50%) 161 (43%) 43 (41%) 71 (34%) 214 (43%)
N: North; NE: Northeast; CW: Central-West; S: South; SE: Southeast; NHL:
non-Hodgkin lymphoma; HL: Hodgkin lymphoma; y: years.
Table 3 - Precursor lymphoid neoplasms in pediatric
patients classified according to cell lineage, gender, and
geographical region distribution for each lineage group.
Region LL B cell LL T cell LL unclassified
Cases (%) F M Total (%) F M Total (%) F M Total (%)
N 19 (7) 1 2 3 (4.3) 6 8 14 (8.7) 0 2 2 (4.7)
NE 64 (23.5) 6 10 16 (23.2) 12 30 42 (26) 4 2 6 (14.3)
CW 20 (7.3) 2 2 4 (5.8) 3 8 11 (6.8) 3 2 5 (12)
S 63 (23.2) 13 6 19 (27.5) 10 18 28 (17.3) 2 14 16 (38)
SE 106 (39) 9 18 27 (39) 18 48 66 (41) 5 8 13 (31)
Total 31 38 69 (100) 49 112 161 (100) 14 28 42 (100)
N: North; NE: Northeast; CW: Central-West; S: South; SE: Southeast; LL:
lymphoblastic lymphoma; F: female; M: male.
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1270MC (92 cases, 19.3%), lymphocyte-rich classical (five cases,
1.1%), lymphocyte depleted (3 cases, 0.6%), and unclassified
(15 cases, 3.2%) and the distribution of the morphologic
subtypes is shown in Table 7. The gender distribution
showed 198 female patients and 278 male patients (ratio
1.5/1).
The mean age was 13.3 years old (female 14 years old and
male 12.8 years old). The results grouped by age for each
geographic region are shown in Fig. 6. The distribution of
the four subtypes of CHL is shown in Table 8.
NLP was diagnosed in 70 cases, 11 female and 59 male
(ratio 6/1). The mean age was 11.2 years old (10.4 years old
for female and 11.4 years old for male). The geographic
region with the largest number of cases was the Northeast
with 25 cases followed by 20 cases in the Southeast. The
proportion of CHL/NLP varied among the regions. CHL
was 8–10 times more frequent than NLP in the Southeast,
the South, and in the Central-West regions but only three to
five times more frequent in the North and Northeast
regions. NLPHL showed an inverse relationship between
Figure 2 - Pediatric mature non-Hodgkin lymphoid neoplasm. A, Global distribution according to cell lineage. B, Specific distribution
according to main subtypes.
Table 4 - Mature B-cell lymphoma in pediatric patients, distribution by gender and geographical areas for each subtype
BL DLBCL Unclassif MZL
F M T (%) F M T (%) F M T (%) F M T (%) Total
N 9 17 26 (9.3) 2 3 5 (5.4) 1 0 1 (8.3) 0 0 0 32 (8.2)
NE 18 65 83 (29.5) 6 21 27 (29.3) 2 0 2 (16.6) 0 1 1 (25) 114 (29.2)
CW 11 15 26 (9.3) 1 4 5 (5.4) 0 1 1 (8.3) 1 1 2 (50) 34 (8.7)
S 9 30 39 (13.9) 7 8 15 (16.4) 1 3 4 (33.3) 0 0 0 58 (14.9)
SE 28 79 107 (38) 12 28 40 (43.5) 3 1 4 (33.3) 1 0 1 (25) 152 (39)
Total 75 206 281 (100) 28 64 92 (100) 7 5 12 (100) 2 2 4 (100) 390 (100)
N: North; NE: Northeast; CW: Central-West; S: South; SE: Southeast; F: female; M: male; BL: Burkitt lymphoma; DLBCL: diffuse large B-cell lymphoma; MZL:
marginal zone lymphoma; the only case of follicular lymphoma was a boy from NE region.
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1271age and frequency, as depicted in Fig. 6. When the
population of each region is taken in to consideration, both
CHL and NLP have a higher incidence in the North.
Comparing all types of lymphomas in all the regions,
CHL and BL were the most prevalent lymphomas, except in
the South where LL was the most frequent (Fig. 7).
The overall distribution of the most frequent pediatric
lymphomas according to the main geographic regions in
Brazil is shown in Fig. 8; the percentages were calculated
Figure 3 - Comparative distribution of all types of pediatric non-Hodgkin lymphomas separated by age group. TCL: T-cell lymphoma;
ALCL: anaplastic large cell lymphoma; ALK: anaplastic large cell lymphoma kinase; Unclass: unclassified; DLBCL: diffuse large B-cell
lymphoma; BL: Burkitt lymphoma; LL: lymphoblastic lymphoma.
Figure 4 - Comparative distribution of all cases of pediatric
lymphomas by age groups in each geographic region. N: North;
NE: Northeast; CW: Central-West; S: South; SE: Southeast.
Figure 5 - Hodgkin lymphoma distribution. CHL: classic Hodgkin
lymphoma; NLPHL: nodular lymphocyte predominant Hodgkin
lymphoma.
Table 6 - Geographic distribution of pediatric Hodgkin
lymphoma.
CHL NLP All cases HL
N 45 (79%) 12 (21%) 57 (100%)
NE 136 (84%) 25 (16%) 161 (100%)
CO 38 (88%) 5 (12%) 43 (100%)
S 63 (89%) 8 (11%) 71 (100%)
SE 194 (91%) 20 (9%) 214 (100%)
CHL: classical Hodgkin lymphoma; NLP: nodular lymphocyte predominant
Hodgkin lymphoma; HL: Hodgkin lymphoma; N: North; NE: Northeast;
CW: Central-West; S: South; SE: Southeast.
Table 5 - Geographic distribution of mature T-cell lymphomas in pediatric patients
ALCL-ALK+ ALCL-ALK- PTLC-NOS T/NK Other
Region F M T (%) F M T (%) F M T (%) F M T (%) F M T (%) Total
N 0 2 2 (3.8) 0 1 1 (11.1) 1 1 2 (8.7) 0 1 1 (20) 0 0 0 6 (6.4)
NE 6 13 19 (35.8) 0 2 2 (22.2) 3 3 6 (26) 0 2 2 (40) 1 1 2 (66.6) 31(33.3)
CW 2 2 4 (7.6) 0 0 0 1 2 3 (13) 0 0 0 0 1 1 (33.3) 8 (8.6)
S 5 5 10 (18.9) 3 1 4 (44.4) 3 1 4 (17.4) 1 0 1 (20) 0 0 0 19 (20.4)
SE 9 9 18 (33.9) 0 2 2 (22.2) 3 5 8 (34.8) 1 0 1 (20) 0 0 0 29 (31.2)
Total 22 31 53 (100) 3 6 9 (100) 11 12 23 (100) 2 3 5 (100) 1 2 3 (100) 93 (100)
N: North; NE: Northeast; CW: Central-West; S: South; SE: Southeast; F: female; M: male; ALCL-ALK+ anaplastic large cell lymphoma; ALK- positive; ALCL-
ALK-: anaplastic large cell lymphoma ALK- negative; PTCL-NOS: peripheral T-cell lymphoma, no-otherwise specified; T/NK: T/NK cell- lymphoma nasal type.
Pediatric lymphomas in Brazil
Gualco G et al.
CLINICS 2010;65(12):1267-1278
1272based on the most frequent types of lymphomas for each
region.
DISCUSSION
Overall, lymphomas are the third most common child-
hood malignancies after acute leukemia and brain tumors,
constituting 10–12% of childhood cancers.
1 In older adoles-
cents, lymphomas surpass brain tumors in incidence,
largely because of the increased frequency of HL in this
age group. NHLs constitute approximately 7–10% of all
cancers in children and adolescents younger than 20 years
of age in the USA.
2,5,11 Although more than 90% of pediatric
NHL are of high-grade histology, over 80% of patients
achieve long-term, event-free survival with current treat-
ment protocols.
In the Surveillance, Epidemiology, and End Results
(SEER) database, the National Cancer Institute in the USA
reported the NHL incidence per 1 000 000 pediatric patients
in different age groups from 1975 to 2000.
23 Patients
younger than 5 years showed an incidence of 2.8 (66 cases),
those 5–9 years old an incidence of 8.8 (147 cases), 10–
14 years old showed an incidence of 14.3 (290 cases), and for
those aged 15 to 19, the incidence was 21.8 (413 cases).
36 For
the period 2001–3, the incidence of lymphoma adjusted by
age in the USA, according to the SEER data, was 27.84 per
million for boys 19 years old and younger and 20.25 for girls
of the same age.
23 Comparatively, in Europe for the same
age range, the highest rate was reported in Italy with 69 and
64 cases per million for boys and girls, respectively.
Germany and Spain have reported a lower incidence with
14 and 6 per million for boys and girls, respectively.
13
Brazil is a large country with marked heterogeneity of
socioeconomic development among its different regions.
23
The population distribution in the five main geographic
regions is as follows: the North, approximately 14 million
(9%) inhabitants; the Northeast, 51 million (28%); the
Southeast, 77 million (42%); the South, 26 million (16%);
and the Central-West, 13 million (8%). As a developing
index, the Minimum National Social Data Set (MNSDS)
evaluated by the Instituto Brasileiro de Geografia e
Estatistica of Brazil
22,37 indicated a childhood mortality rate
of 34.8 per 1000 children under 5 years of age. In the
Northeast region of Brazil, a region of lower socioeconomic
status, this rate reaches 53 per 1000, showing the great
heterogeneity of the country. Also, Brazil is a country where
undernourishment and endemic infections are common
public health problems,
37 especially in some geographic
areas such as the Northeast and the North.
In 2009, the Brazilian National Cancer Institute (INCA)
registry data indicated that patients younger than 19 years
represented 2.8% of all types of cancer in all ages. The types
of malignancy in this age group were distributed as follows:
carcinomas (28%), leukemias (15%), malignant bone tumors
(14%), lymphomas (10%), soft tissue (7.3%), renal neoplasias
(6.2%), and central nervous system tumors (6%).
24 In the
Brazilian study performed by the population-base cancer
registires,
23 the global incidence of lymphomas for males
under 19 years old reached the highest rate in the Southeast
region with 69.4 cases per million and the lowest in the
North region with 17.5 cases per million. In females in this
age group, the highest rate was 32.8 cases per million in
the Northeast region, and the lowest was 6.2 cases per
million in the North region. These incidence rates included
both HLs and NHLs along with histiocytic neoplasia. In
Table 7 - Geographic distribution of CHL morphologic subtypes.*
NS MC LD LR
Region F M S/T F M S/T F M S/T F M S/T
N 9 23 32 4 6 10 0 0 0 0 0 0
NE 43 55 98 9 19 28 1 2 3 0 2 2
CW 16 15 31 2 2 4 0 0 0 0 0 0
S 2 82 25 0 3 9 1 2 0 000 00
SE 76 74 150 3 35 38 0 0 0 2 1 3
T 172 189 361 21 71 92 1 2 3 2 3 5
*15 unclassified cases are not included in the table. NS: nodular sclerosis; MC: mixed cellularity; LD: lymphocyte depletion; LR: lymphocyte rich; M: male; F:
female; S/T: subtotal of each subgroup; T: total; N: North; NE: Northeast; CW: Central-West; S: South; SE: Southeast.
Figure 6 - Classical Hodgkin lymphoma and nodular predomi-
nance lymphocyte Hodgkin lymphoma distribution in all age
groups.
Table 8 - Distribution of pediatric classical Hodgkin
morphologic subtypes according to age.
Age
(years) NS (%) MC (%) LD (%) LR (%) U (%) Total (%)
0–5 14 (66.6) 6 (28.6) 0 0 1 (4.8) 21 (100)
6–10 63 (61.2) 30 (29.2) 1 (0.9) 2 (1.9) 7 (6.8) 103 (100)
11–14 91 (72.8) 27 (21.6) 1 (0.8) 2 (1.7) 4 (3.2) 125 (100)
15–18 193 (85) 29 (12.8) 1 (0.4) 1 (0.4) 3 (1.2) 227 (100)
Total 361 (75.8) 92 (19.3) 3 (0.6) 5 (1) 15 (3.2) 476 (100)
NS: nodular sclerosis; MC: mixed cellularity; LD: lymphocyte depletion; LR:
lymphocyte rich; U: unclassified.
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1273these studies, however, there was no discrimination of
lymphoma subtypes.
We need to stress that the current study is not a formal
epidemiology study, and may show a significant case
selection bias depending on the referral patterns to our
laboratory from each region in Brazil. Nonetheless, we
believe it probably represents the most reliable data on
pediatric lymphomas in Brazil. In the present study of 1301
cases of lymphoma, the global distribution of lymphoma
subtypes was 68% NHL and 32% HL. Comparing the
frequency of each group with other studies, high-grade B-
cell lymphomas are by far the most common, as has been
seen in the USA and European countries.
8,10
The population of Brazil, formed by extensive admixture
between Amerindians, Europeans, and Africans, is one of
the most variable in the world, as a result of five centuries
of interethnic crossing between peoples from three conti-
nents. A recent study using ancestry-informative molecular
Figure 7 - Distribution of all cases of pediatric lymphomas according to geographic regions. A: North, B: Northeast, C: Central-West, D:
SouthE, Southeast. LL: lymphoblastic lymphoma; BL: Burkitt lymphoma; DLBCL: diffuse large B-cell lymphoma; Unclass: unclassified;
ALCL: anaplastic large cell lymphoma; ALK: anaplastic large cell lymphoma kinase; T/NK nasal: T/K lymphoma ‘‘nasal type’’; T-NOS:
peripheral T-cell lymphoma not otherwise specified; NLP: nodular lymphocyte predominant; CHL: classic Hodgkin lymphoma.
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1274markers concluded that in Brazil at an individual level,
color, as determined by physical evaluation, was a poor
predictor of genomic ancestry.
38 Thus, these parameters
were not considered in our analysis.
In reference to different lymphoma subtypes, LL accounts
for approximately 20–30% of all NHL in childhood.
4,7,8
Lymphoblastic lymphomas are usually positive for TdT,
with more than 75% having a T-cell immunophenotype and
the remainder having a precursor B-cell phenotype.
7,8,39
Azevedo-Silva et al.
40 showed in a Brazilian epidemiology
study of three cities that the frequency of lymphoblastic
disease varies from 15% to 35% among all malignant
diseases in pediatric patients.
40 In our study, LL represented
36% of all NHLs (272 cases), with 65% being male (male–
female ratio of 1.8/1.0). The T-cell phenotype was the most
prevalent at 60%, 25% were of the B-cell phenotype, and the
remaining 15% were unclassified. These results are coin-
cident with those observed in Western countries: 75% of the
LL having T- or null-cell phenotype and the remaining cases
showing the B-cell phenotype.
8,10
In the present series, 483 cases corresponded to mature cell
lymphomas, with 81% belonging to the B-cell and 19% the
mature T-cell lineage. The global results obtained in our
series of pediatric lymphomas mirror the data in the
population-based registry.
23 BL is the most prevalent mature
B-cell lymphoma in pediatric/adolescent patients.
12,31,37,41 In
our series, this corresponded to 281 cases (37% of all NHL).
In a previous study, our group found that BL in Brazilian
patients, including both children and adults, shows inter-
mediate features between endemic and epidemic cases and
predominates in the Northeast region.
31
In the study by Sandlund et al.,
8 BL corresponded to 40%
of NHL in pediatric patients. Lones et al.
12 found 47% of BL
in a series of mature B-cell lymphomas in children/
adolescents belonging to three reference centers (USA,
France, and the United Kingdom). Considering only the
mature B-cell lymphomas in the present series, BL corre-
sponded to 72%, a much higher frequency than the Lones
series.
12 On the other hand, we only found 20% of DLBCL
compared with 34% in their study. We considered 3% of the
cases unclassified with features intermediate between BL
and DLBCL. Lones et al.
12 reported 11% of Burkitt-like
lymphoma, but we cannot assume all these cases were
unclassified as proposed by the present WHO classifica-
tion.
35 Ferreira et al.
26 found 78.2% of the lymphomas in
children from the Northeast region of Brazil corresponded
to BL.
The geographic distribution of our cases of BL showed a
higher frequency in the Southeast region (38%), followed by
the Northeast (30%), and 14%, 9%, and 9% for the South, the
Central-West, and the North regions, respectively. Male
gender predominated with a rate of 2.7/1, similar to
previously reported data.
8,12,26 Considering all these data,
we can speculate that BL may have a higher incidence in
the Northeast than in other geographic regions, which
may be associated to region-specific environmental factors.
Figure 8 - Overall distribution of the most frequent pediatric lymphomas according to main geographic regions in Brazil.
Footnote: LL: lymphoblastic lymphoma; BL: Burkitt lymphoma; ALCL: anaplastic large cell lymphoma; HL: Hodgkin lymphoma.
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1275Furthermore, these data underscore the need for epidemio-
logical studies involving different regions of the country.
DLBCLs are quite infrequent in the pediatric population.
In this series, they represented 7% of all lymphomas and
20% of mature B-cell lymphomas; 24% of primary mediast-
inal B-cell lymphoma were included with DLBCL-NOS.
42–44
Considering that the representation of the global population
in Brazil is 28% and 42% for the Northeast and the Southeast
regions, respectively, it seems that the DLBCL frequency
related to the global population is probably the same in both
regions. Nine cases of DLBCL were diagnosed as histiocy-
tic/T-cell rich B-cell lymphomas. It is worth noting that this
type is infrequently reported in children.
32,45–49
Low-grade B-cell lymphomas are extremely rare in
children and adolescents.
10,50–54 We found only five cases,
one follicular lymphoma and four extranodal marginal zone
lymphomas, corresponding to 1.2% of mature B-cell lym-
phomas and 0.6% of all NHL. The Follicular lymphoma was
nodal and the four marginal zone lymphomas were
extranodal, one intestinal and three gastric.
Most of the cases of mature T-cell NHL described in
children are ALCL-ALK-positive, with other types rare.
8 In
our series of mature T-cell NHL, 57% (53 cases) corre-
sponded to ALCL ALK-positive, and 10% (9 cases) corre-
sponded to the ALK–negative type. The second, more
frequent mature T-cell lymphoma in our series was peri-
pheral T-cell lymphoma, NOS, with 23 cases (25% of the
cases) found. Only five cases of T/NK nasal-type lympho-
mas were diagnosed in this series. This frequency is
somewhat high compared with series in Western coun-
tries.
10,33,55,56 Unfortunately, information about HTLV-1
serological status was not usually available in our study.
HL is an uncommon disorder with an annual incidence of
2–3/100 000 in Europe and the USA.
7 In developed
countries, the onset of HL shows a bimodal distribution
with a first peak in young adults and a second peak after
50 years of age. In underdeveloped countries or developing
countries, the first peak occurs predominantly in infancy,
and its incidence seems to decrease with age.
17,23 In the
pediatric population as well as in adults, most of the cases
are CHL. It has been demonstrated that childhood HL
displays characteristic epidemiological, clinical, and patho-
logical features according to various geographic areas,
particularly according to the socioeconomic level of a given
country.
18 In emerging countries there is a higher male–
female ratio, a younger age of presentation, a high pro-
portion of advanced stages, and MC as the most common
subtype.
22,25,55,57,58
Our series of 546 HLs included 476 (87%) CHLs and 70
(13%) NLPHLs in all geographic regions of Brazil. We
recognized 476 cases of CHL, corresponding to 87% of HL
and 37% of all lymphomas (HL and NHL). Nodular
lymphocyte predominance corresponded to 70 cases (13%
of HL and 7% of all lymphomas), having a higher frequency
in the Northeast and the North areas of the country. The
frequency in the South and the Southeast is similar to that
reported in Western countries.
59 To the best of our knowl-
edge, this is the highest number of pediatric/adolescent
NLPHL reported in one series in the English literature. In
Brazil, HL seems to be frequent in children,
27,29,57 and its
association with EBV is well-established.
23,34,60 There are no
studies reporting exclusively on pediatric HL Brazilian
cases that included the entire country. Epidemiological data
in two studies,
30,60 including one with a large number of
cases from Sao Paulo State, which has a higher socio-
economic level than the rest of the country, showed similar
characteristics as industrialized countries. These studies
included adult patients.
30 In other reports comparing two
regions—one with a high and the other with a low socio-
economic status—the difference was significant in terms of
EBV infection and histologic subtypes.
60
In 323 patients under 20 years with HL from the Southeast
region,
30 304 (94%) were CHL and 21 were NLP (6%). The
male–female ratio was 1.51 for CHL and 31 for NLP. Our
series of 546 HL included 476 cases (87%) of CHL and 70
cases (13%) of NLPHL in all geographic regions of Brazil.
CHL distribution among all the different regions showed
that the Southeast had 194 cases (41%), and the Northeast
had 136 cases (29%), while the South, North and Central-
West regions had 13%, 9%, and 8% of the cases, respectively.
On the other hand, a higher number of cases of NLPHL was
observed in the Northeast region with 365, while the
Southeast had 29% of the cases. When this is considered
for each region separately, the frequency for both main
groups of HL showed that the Southeast region had 91% of
CHL and 9% of NLP, and the Northeast region had 84% of
CHL and 16% of NLP. Even a higher relative frequency of
NLPHL was observed in the North region with 22.2% of the
cases and 77.8% of CHL, which shows an important
difference in the NLPHL frequency between the North/
Northeastern areas of the country in relation to the Southern
region. As EBV is usually not associated with NLPHL,
it may be possible that another epidemiological factor
is involved to explain the differences between the North
of the country and the Southeast/South; this raises a new
question that may be answered in future studies. The
gender distribution for both main types of HL demonstrated
an important variation in the male–female ratio with
NLPHL showing a male–female ratio of 61, with CHL only
1.41.
In general, it has been described that MC is the most
prevalent CHL subtype in children in underdeveloped
countries.
61,62 We found NS to be the most frequent subtype
(361 cases, 76.9%). Considering only the 124 cases in 10-
year-olds or younger, NS constituted 62% of this group, and
MC constituted 30%. On the other hand, older patients
(older than 11 years old) comprised 80.7% of NS but only
15.9% of MC. Mixed cellularity HL is the second most
common subtype in pediatric patients in Brazil, affecting
mainly the younger population.
It has been described that NLPHL and MCHL subtypes
are more common in the prepubertal child, accounting for
10–12% and 30–35% of HL, respectively. Nodular sclerosis
occurs in 45–50% of children, in contrast to 70–80% of young
adults and adolescents.
61,63 We found almost 50% of the
cases of NLPHL in patients 10 years old or younger, in
contrast to 26% of CHL. Nodular lymphocyte predominance
occurred more frequently in children with a male–female
ratio of approximately 51.
62,63 Araujo et al.,
34 in a series of
pediatric HL from the Bahia state (Northeast region), found
a marked predominance of MC. Elgui et al.
60 described a
high prevalence of MC in children and adults from the
North compared with the Southeast, where the distribution
of MC and NS was similar. Vassallo et al.
30 studying
patients from the Southeast region only, including both
adults and children, found a 70% incidence of the NS
subtype. Chabay et al.
16 described similar results in a
pediatric group from Rio de Janeiro (Southeast region).
Pediatric lymphomas in Brazil




65 NS is the predominant subtype
in both adults and pediatric patients. It is worth mentioning
that in all these studies on HL, the number of cases of
NLPHL in pediatric patients is very low. Sandoval et al.
62
described a large series of NLPHL in patients under 21 years
old. Eight-five percent of their cases were male, and the
mean age was 10.5 years old. In our series of 70 NLPHL
cases, 84.5% of the cases were male, and the mean age was
10.8 years old. Almost half of our cases (34/70, 48%) were
under 10 years old, while in the study of Sandoval et al.
62
there were 19/51 cases (37%) under 10 years old.
In conclusion, this study, provides objective information
on histological subtypes of a large number of pediatric
lymphomas giving an overview of these diseases in the
whole country according to the histopathological WHO
2008 classification of hematopoietic neoplasms.
35
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